This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings: Archive
Compared to Estimates, Datadog (DDOG) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Datadog (DDOG) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
DDOGPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Pediatrix Medical's Q2 Earnings Beat on Strong Patient Volumes
by Zacks Equity Research
MD's Q2 earnings benefit from higher patient volumes and a declining expense level. It now projects 2025 adjusted EBITDA within $245-$255 million, up from the prior view of $220-$240 million.
EWPositive Net Change THCPositive Net Change MDNegative Net Change HCAPositive Net Change
earnings medical
Citizens & Northern (CZNC) Misses Q2 Earnings Estimates
by Zacks Equity Research
Citizens & Northern (CZNC) delivered earnings and revenue surprises of -14.89% and +4.62%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CZNCPositive Net Change BAPPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Vistra Q2 Earnings Beat Estimates, Revenues Miss, Both Up Y/Y
by Zacks Equity Research
Vistra tops second-quarter earnings estimates despite sales miss, and pushes ahead with clean energy projects and share buybacks.
EXCNegative Net Change NEENegative Net Change AEPNegative Net Change VSTPositive Net Change
earnings utilities
Compared to Estimates, Sotera Health (SHC) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
SHCNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Restaurant Brands Q2 Earnings Miss Estimates, Rise Y/Y, Stock Down
by Zacks Equity Research
QSR's Q2 earnings miss estimates but rise Y/Y, with sales growth led by Tim Hortons and International units.
BJRINegative Net Change CAKEPositive Net Change LOCOPositive Net Change QSRPositive Net Change
earnings restaurants retail
Lamar Stock Falls Despite Q2 AFFO Beat, Revenues Increase Y/Y
by Zacks Equity Research
LAMR's Q2 results reflect growth in revenues. However, a higher component of expenses marred the performance to some extent.
PLDNegative Net Change CCINegative Net Change LAMRNegative Net Change
earnings finance reit
DBX Q2 Earnings Beat Estimates, Revenues Fall Y/Y, Shares Rise
by Zacks Equity Research
Dropbox tops Q2 earnings estimates with strong margins and cash flow, despite revenue and user declines from FormSwift pullback.
CSCOPositive Net Change VIPSNegative Net Change LITEPositive Net Change DBXPositive Net Change
artificial-intelligence earnings tech-stocks
Docebo Inc. (DCBO) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Docebo (DCBO) delivered earnings and revenue surprises of +45.00% and +2.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DCBOPositive Net Change INTANegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Surging Earnings Estimates Signal Upside for K12 (LRN) Stock
by Zacks Equity Research
K12 (LRN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
LRNNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why Holley (HLLY) Might be Well Poised for a Surge
by Zacks Equity Research
Holley Inc. (HLLY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
HLLYPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why InfuSystems Holdings (INFU) Might be Well Poised for a Surge
by Zacks Equity Research
InfuSystems Holdings, Inc. (INFU) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
INFUPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Rigel (RIGL): Time to Buy?
by Zacks Equity Research
Rigel Pharmaceuticals (RIGL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
RIGLNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Tree.com (TREE): Time to Buy?
by Zacks Equity Research
Tree.com (TREE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
TREENegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Starwood Property Shares Up on Q2 Earnings Beat, Expenses Decline Y/Y
by Zacks Equity Research
STWD stock rises 1.9% as Q2 earnings beat estimates, due to lower expenses despite revenue and BVPS declines.
STWDNegative Net Change ARIPositive Net Change NLYPositive Net Change
earnings finance
Inogen Stock Gains Following Q2 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
INGN stock rises as Q2 loss narrows and revenue climbs 4% year over year, driven by strong B2B demand despite DTC and rental declines.
BSXNegative Net Change WSTNegative Net Change INGNPositive Net Change MEDPNegative Net Change
earnings medical medical-devices
PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises
by Zacks Equity Research
PACB stock jumps after Q2 results beat estimates, with narrow losses, rising margins, and strong global demand.
BSXNegative Net Change WSTNegative Net Change PACBNo Net Change MEDPNegative Net Change
earnings medical medical-devices
Take-Two's Q1 Loss Narrows Year Over Year, Revenue Growth Continues
by Zacks Equity Research
TTWO rides strong engagement in NBA 2K25 and mobile, shrinking fiscal Q1 loss and posting 12.4% revenue growth.
TTWOPositive Net Change AMCNegative Net Change AFYAPositive Net Change ASNegative Net Change
consumer-discretionary earnings mobile tech-stocks
DASH Q2 Benefits From Strong Marketplace GOV: Time to Buy the Stock?
by Zacks Equity Research
DoorDash's second-quarter results benefit from surging Marketplace GOV, record order frequency, and expanding ad revenues.
CSCOPositive Net Change ADSKPositive Net Change AMATPositive Net Change DASHPositive Net Change
earnings tech-stocks
Brighthouse Financial Q2 Earnings Miss Estimates on Lower Premiums
by Zacks Equity Research
BHF posts Q2 earnings drop on lower premiums and investment income, despite a sharp cut in total expenses.
LNCPositive Net Change RGANegative Net Change VOYANegative Net Change BHFNegative Net Change
earnings finance insurance
Akamai Q2 Earnings Surpass Estimates, Revenues Increase Y/Y
by Zacks Equity Research
AKAM posts Q2 revenue and earnings beats on strong security and cloud demand across multiple end markets.
AKAMPositive Net Change JBLPositive Net Change MSIPositive Net Change UIPositive Net Change
communications earnings tech-stocks
CBL Stock Rises Following Q2 Earnings and Mall Acquisitions
by Zacks Equity Research
CBL Properties' second-quarter 2025 results benefit from strong leasing gains and four major mall acquisitions, boosting cash flow and a higher dividend.
CBLPositive Net Change
earnings reit
DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down
by Zacks Equity Research
Doximity beats first-quarter fiscal 2026 estimates with double-digit revenue growth and lifts its full-year forecast.
BSXNegative Net Change WSTNegative Net Change DOCSPositive Net Change GEHCNegative Net Change
earnings medical medical-devices
Microchip Q1 Earnings Beat Estimates, Sales Down Y/Y, Shares Drop
by Zacks Equity Research
MCHP's Q1 earnings and sales beat estimates despite steep yearly declines, with Q2 guidance signaling sequential growth ahead.
CSCOPositive Net Change MCHPNegative Net Change VIPSNegative Net Change LITEPositive Net Change
earnings semiconductor tech-stocks
AMN Stock Slips Despite Q2 Earnings & Revenue Beat, Margins Down
by Zacks Equity Research
AMN Healthcare tops second-quarter 2025 earnings and revenue forecasts, but margins and segment sales face continued pressure.
BSXNegative Net Change AMNNegative Net Change WSTNegative Net Change GEHCNegative Net Change
earnings medical medical-devices